Daiichi Sankyo acquires Plexxikon

[News]

Plexxikon Inc. today announced that its acquisition by Daiichi Sankyo Company, Limited, a Japan-based global pharmaceutical company, has been successfully completed. Clearance under the Hart Scott Rodino Antitrust Improvements Act has been received. Under the terms of the deal, Plexxikon shareholders will receive $805 million up-front, with near-term milestone payments associated with the approval of PLX4032 totaling an additional $130 million.

More... (http://www.news-medical.net/news/20110404/Daiichi-Sankyo-acquires-Plexxikon.aspx)